News

Filter

Current filters:

None

Popular Filters

7895 to 7919 of 8758 results

GlaxoSmithKline launches $50 million Life Sciences Innovation Fund in Canada

13-11-2011

UK pharma giant GlaxoSmithKline (LSE: GSK) has launched the GSK Canada Life Sciences Innovation Fund,…

FinancialGlaxoSmithKlineNorth AmericaPharmaceuticalResearch

Daiichi Sankyo to license ARQ 092 from ArQule, under joint AKIP research collaboration

11-11-2011

Japanese drug major Daiichi Sankyo (TSE 4568) says it has executed a license agreement with USA-based…

ArQuleDaiichi SankyoLicensingOncologyPharmaceuticalResearch

Servier partners with Canada’s Prognomix on type 2 diabetes research

11-11-2011

Independent French drugmaker Laboratoires Servier has entered into an R&D agreement with privately-held…

DiabetesLicensingPharmaceuticalPrognomixResearchServier

India’s Ranbaxy posts 3rd-qtr 2011 loss

10-11-2011

India’s largest drugmaker, Ranbaxy Laboratories (RANB: BO) posted its biggest quarterly loss in…

FinancialGenericsRanbaxy Laboratories

FDA priority review for Roche/Genentech’s vismodegib for skin cancer

10-11-2011

The US Food and Drug Administration has accepted and filed Swiss drug major Roche (ROG: SIX) subsidiary…

BiotechnologyCurisGenentechNorth AmericaOncologyPharmaceuticalRegulationRochevismodegib

Japanese pharma companies set to go global - by P Reed Maurer

10-11-2011

In a short time much can change in Japan. A striking example is the move by Japanese pharmaceutical companies…

Asia-PacificLicensingMergers & AcquisitionsPharmaceutical

UK’s NICE says no to AstraZeneca breast cancer drug Faslodex

10-11-2011

There was negative news this morning for Anglo-Swedish drug major AstraZeneca (LSE: AZN), when the UK’s…

AstraZenecaEuropeFaslodexOncologyPharmaceuticalPricingRegulation

Letter to the Editor: Canadian intellectual property

10-11-2011

Dear, The Pharma Letter: The characterization of the CMAJ article by Paul Grootendorst and Aidan Hollis…

GenericsNorth AmericaPatentsPharmaceutical

Kohl-Grassley generic drug bill would save US taxpayers nearly $4.8 billion, says CBO

09-11-2011

A new estimate from the USA’s Congressional Budget Office (CBO) estimate finds that a bipartisan…

GenericsNorth AmericaPatentsPharmaceuticalPoliticsPricing

Salix Pharma to buy Oceana for $300 million; posts 3rd-qtr profit

09-11-2011

With the aim of improving its innovate products franchise, US drugmaker Salix Pharmaceuticals (Nasdaq:…

FinancialMergers & AcquisitionsOceana TherapeuticsPharmaceuticalSalix Pharmaceuticals

Merck Serono expands osteoarthritis collaboration with Ablynx

09-11-2011

Merck Serono, a division of Germany’s Merck KGaA (MRK: DE) has entered into a third agreement with…

AblynxAnti-Arthritics/RheumaticsLicensingMerck SeronoPharmaceuticalResearch

Timothy Wright named global head, development, at Novartis Pharma

09-11-2011

Swiss drug major Novartis (NOVN: VX) announced the appointment of Timothy Wright, as global head, development,…

ManagementNovartisPharmaceutical

Number of monoclonal antibody products in development continues to increase, says Tufts CSDD

09-11-2011

Developers are steadily increasing the number of monoclonal antibody products - known as MAbs - for which…

BiotechnologyImmunologicalsOncologyResearch

Disappointment for AstraZeneca and Targacept as antidepressant fails to meet Ph III endpoint

09-11-2011

Anglo-Swedish drug major AstraZeneca (LSE: AZN) and Targacept (Nasdaq: TRGT) yesterday reported disappointing…

AstraZenecaNeurologicalPharmaceuticalResearchTargacept

7895 to 7919 of 8758 results

Back to top